EBR Systems, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EBRCZ research report →
Price Chart
About the company
EBR Systems, Inc. focuses on developing internal medical devices that utilize wireless technology for tissue stimulation. A key offering is their WiSE cardiac resynchronization therapy (CRT) system, which leverages proprietary cable-free technology to deliver electrical pacing directly into the heart's left ventricle.
- CEO
- John Graham McCutcheon
- IPO
- 2023
- Employees
- 135
- HQ
- Sunnyvale, CA, US
Get TickerSpark's AI analysis on EBRCZ
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
- Market Cap
- $127.70M
- P/E
- -1.64
- Fwd P/E
- 0.24
- PEG
- -0.10
- P/S
- 11.35
- P/B
- 1.14
- EV/EBITDA
- -1.31
- Div Yield
- 0.00%
- Gross Margin
- 14.52%
- Op Margin
- -900.44%
- Net Margin
- -947.48%
- ROE
- -169.40%
- ROIC
- -44.57%
Latest fiscal year · YoY change
- Revenue
- $1.62M+0.0%
- Gross Profit
- $490.00K+188.9%
- Op Income
- $-47,690,606
- Net Income
- $-48,758,000-141.7%
- EPS
- $-0.12+0.0%
- OCF Growth
- -29.0%
- FCF Growth
- -37.0%
- 52W High
- $1.50
- 52W Low
- $0.16
- 50D MA
- $0.22
- 200D MA
- $0.41
- Beta
- 0.52
- RSI (14)
- 38
- Avg Volume
- 5.84K
No earnings-call transcripts are available for EBRCZ yet.
- Free Float
- 83.3%
- Shares Outstanding
- 638.49M
- Float Shares
- 531.63M
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 21, 26 | Host-Plus Pty Ltd as trustee for the HOSTPLUS Pooled Superannuation Trust | buy | 7,700,119 |
| Oct 16, 24 | Evans Bronwyn | other | 8,370 |
| Oct 16, 24 | Evans Bronwyn | other | 8,370 |
| Sep 30, 24 | Carnegie Mark H. | other | 0 |
| Sep 30, 24 | Carnegie Mark H. | other | 0 |
| Sep 30, 24 | Carnegie Mark H. | other | 0 |
| Sep 30, 24 | Carnegie Mark H. | other | 0 |
| Sep 30, 24 | Carnegie Mark H. | other | 0 |
| Oct 29, 17 | Carnegie Mark H. | other | 1,950,607 |
| Oct 4, 21 | Carnegie Mark H. | other | 378,575 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our EBRCZ coverage
Recent articles, reports, and earnings notes.
No research on EBRCZ yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate EBRCZ report →